GSK Investigational Site

Wilson, North Carolina 27893

2 studies enrolling now · 3 studies all time

What they study most

Metabolic Dysfunction-Associated Steatohepatitis, Multiple Myeloma, Neoplasms, Breast, Non-alcoholic Fatty Liver Disease

Studies at this site

• A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments — Recruiting now
• A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH — Recruiting now
• Treatment With Pazopanib for Neoadjuvant Breast Cancer — Completed